Moreover, a significant reduction in the expression levels of nuclear factor-kappa B (NF-kB) and IL-6 was observed in obese patients with NAFLD after OEA supplementation (Tutunchi et al., 2021). The gene discussed is NFKB1; the disease is metabolic dysfunction-associated steatotic liver disease.